STOCK TITAN

Form 144: ALHC proposed sale of 51,379 RSU shares on 10/09/2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filing for proposed sale of $908,894.51 in common stock (51,379 shares) with an approximate sale date of 10/09/2025. The shares were acquired as Restricted Stock Units on 10/04/2025 and show 51,379 units to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The filing lists 198,031,417 shares outstanding, and records prior 10b5-1 sales by the same account totaling 62,000 shares during August 2025 for aggregate gross proceeds of $946,833.62 across three trades. Certain standard issuer identification fields (issuer name and SEC file number) are not populated in the visible text, so the filing cannot be tied to an issuer by name from this extract.

Positive

  • Planned sale is disclosed publicly, supporting regulatory transparency
  • Broker listed (Morgan Stanley Smith Barney LLC), indicating institutional execution

Negative

  • Issuer name and SEC file number are not provided in the visible extract, limiting issuer identification
  • Large insider sales year-to-date (62,000 shares sold in August 2025 plus 51,379 proposed) which may increase share supply

Insights

Insider plans to sell recently vested RSUs and has executed prior 10b5-1 sales this year.

The filing documents a proposed sale of 51,379 common shares acquired as Restricted Stock Units on 10/04/2025, with an expected sale value of $908,894.51 on 10/09/2025. Sales are routed through Morgan Stanley Smith Barney LLC on NASDAQ, indicating use of an institutional broker for an orderly disposition.

Prior 10b5-1 executions show systematic selling in August 2025 totaling 62,000 shares and gross proceeds of $946,833.62, which suggests continued vesting-driven or plan-driven liquidity rather than an isolated trade. Monitor the completion date 10/09/2025 and any subsequent filings for cumulative insider sales against outstanding share count of 198,031,417.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for ALHC show about the proposed sale?

The form shows a proposed sale of 51,379 common shares valued at $908,894.51, with an approximate sale date of 10/09/2025 via NASDAQ.

How were the shares being sold acquired?

The shares were acquired as Restricted Stock Units (RSUs) on 10/04/2025, with the same date listed for acquisition and payment.

Has the filer sold shares recently?

Yes. The filing records three 10b5-1 sales in August 2025 totaling 62,000 shares for aggregate gross proceeds of $946,833.62.

How many shares does the company have outstanding according to the filing?

The filing lists 198,031,417 shares outstanding.

Who is the broker handling the proposed sale?

The broker is listed as Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.
Alignment Healthcare, Inc.

NASDAQ:ALHC

ALHC Rankings

ALHC Latest News

ALHC Latest SEC Filings

ALHC Stock Data

4.72B
179.82M
3.91%
96.87%
6.09%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
ORANGE